Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017674012> ?p ?o ?g. }
- W2017674012 endingPage "164" @default.
- W2017674012 startingPage "157" @default.
- W2017674012 abstract "To assess whether the content of Scientific Advice (SA) questions addressed to a national drug regulatory agency is associated with company size. This may help to increase understanding about the knowledge, strategic, and regulatory gaps companies face during drug development. A cross-sectional analysis was performed of SA provided by the Dutch Medicines Evaluation Board (MEB) in 2006–2008. Definition of company size was based on ranking by total revenues (Scrip’s Pharmaceutical Company League Tables 2008). The content of each SA question was scored according to predefined domains (quality, nonclinical, clinical, regulatory, and product information), their subdomains (e.g., efficacy), and a selection of additional content variables (e.g., endpoints, choice of active comparator). In total, 201 SA documents including 1,087 questions could be identified. Small, medium-sized, and large companies asked for SA 110 (54.7%), 40 (19.9%), and 51 (25.4%) times, respectively. Clinical questions were asked most often (65.9%), mainly including efficacy (33.2%) and safety questions (24.0%). The most frequent topics were overall efficacy and safety strategy. Small companies asked quality and nonclinical questions more often (P < 0.001) and clinical questions less frequently than large companies (P = 0.004). Small companies asked significantly more clinical questions about pharmacokinetics, including bioequivalence, than medium-sized and large companies (P < 0.001). The array of topics addressed in SA provides an interesting outlook on what industry considers to be still unresolved in drug development and worthwhile to discuss with regulators. Company size is associated with the content of SA questions. MEB advice accommodates both innovative and noninnovative drug development." @default.
- W2017674012 created "2016-06-24" @default.
- W2017674012 creator A5032508279 @default.
- W2017674012 creator A5035747289 @default.
- W2017674012 creator A5041722553 @default.
- W2017674012 creator A5045678150 @default.
- W2017674012 creator A5082115427 @default.
- W2017674012 date "2010-11-04" @default.
- W2017674012 modified "2023-10-15" @default.
- W2017674012 title "Regulatory scientific advice in drug development: does company size make a difference?" @default.
- W2017674012 cites W1995486476 @default.
- W2017674012 cites W2067460372 @default.
- W2017674012 cites W2159217136 @default.
- W2017674012 cites W2165711866 @default.
- W2017674012 cites W2169795103 @default.
- W2017674012 doi "https://doi.org/10.1007/s00228-010-0919-x" @default.
- W2017674012 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3021701" @default.
- W2017674012 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21049297" @default.
- W2017674012 hasPublicationYear "2010" @default.
- W2017674012 type Work @default.
- W2017674012 sameAs 2017674012 @default.
- W2017674012 citedByCount "12" @default.
- W2017674012 countsByYear W20176740122012 @default.
- W2017674012 countsByYear W20176740122013 @default.
- W2017674012 countsByYear W20176740122014 @default.
- W2017674012 countsByYear W20176740122015 @default.
- W2017674012 countsByYear W20176740122016 @default.
- W2017674012 countsByYear W20176740122019 @default.
- W2017674012 countsByYear W20176740122020 @default.
- W2017674012 crossrefType "journal-article" @default.
- W2017674012 hasAuthorship W2017674012A5032508279 @default.
- W2017674012 hasAuthorship W2017674012A5035747289 @default.
- W2017674012 hasAuthorship W2017674012A5041722553 @default.
- W2017674012 hasAuthorship W2017674012A5045678150 @default.
- W2017674012 hasAuthorship W2017674012A5082115427 @default.
- W2017674012 hasBestOaLocation W20176740121 @default.
- W2017674012 hasConcept C111472728 @default.
- W2017674012 hasConcept C112705442 @default.
- W2017674012 hasConcept C119857082 @default.
- W2017674012 hasConcept C121955636 @default.
- W2017674012 hasConcept C126322002 @default.
- W2017674012 hasConcept C138885662 @default.
- W2017674012 hasConcept C142724271 @default.
- W2017674012 hasConcept C144133560 @default.
- W2017674012 hasConcept C162853370 @default.
- W2017674012 hasConcept C17744445 @default.
- W2017674012 hasConcept C189430467 @default.
- W2017674012 hasConcept C19351080 @default.
- W2017674012 hasConcept C195487862 @default.
- W2017674012 hasConcept C2524010 @default.
- W2017674012 hasConcept C2776876202 @default.
- W2017674012 hasConcept C2778917124 @default.
- W2017674012 hasConcept C2779530757 @default.
- W2017674012 hasConcept C2779652045 @default.
- W2017674012 hasConcept C2780035454 @default.
- W2017674012 hasConcept C3019398576 @default.
- W2017674012 hasConcept C3116431 @default.
- W2017674012 hasConcept C33923547 @default.
- W2017674012 hasConcept C41008148 @default.
- W2017674012 hasConcept C42404028 @default.
- W2017674012 hasConcept C535046627 @default.
- W2017674012 hasConcept C71924100 @default.
- W2017674012 hasConcept C90673727 @default.
- W2017674012 hasConcept C98274493 @default.
- W2017674012 hasConceptScore W2017674012C111472728 @default.
- W2017674012 hasConceptScore W2017674012C112705442 @default.
- W2017674012 hasConceptScore W2017674012C119857082 @default.
- W2017674012 hasConceptScore W2017674012C121955636 @default.
- W2017674012 hasConceptScore W2017674012C126322002 @default.
- W2017674012 hasConceptScore W2017674012C138885662 @default.
- W2017674012 hasConceptScore W2017674012C142724271 @default.
- W2017674012 hasConceptScore W2017674012C144133560 @default.
- W2017674012 hasConceptScore W2017674012C162853370 @default.
- W2017674012 hasConceptScore W2017674012C17744445 @default.
- W2017674012 hasConceptScore W2017674012C189430467 @default.
- W2017674012 hasConceptScore W2017674012C19351080 @default.
- W2017674012 hasConceptScore W2017674012C195487862 @default.
- W2017674012 hasConceptScore W2017674012C2524010 @default.
- W2017674012 hasConceptScore W2017674012C2776876202 @default.
- W2017674012 hasConceptScore W2017674012C2778917124 @default.
- W2017674012 hasConceptScore W2017674012C2779530757 @default.
- W2017674012 hasConceptScore W2017674012C2779652045 @default.
- W2017674012 hasConceptScore W2017674012C2780035454 @default.
- W2017674012 hasConceptScore W2017674012C3019398576 @default.
- W2017674012 hasConceptScore W2017674012C3116431 @default.
- W2017674012 hasConceptScore W2017674012C33923547 @default.
- W2017674012 hasConceptScore W2017674012C41008148 @default.
- W2017674012 hasConceptScore W2017674012C42404028 @default.
- W2017674012 hasConceptScore W2017674012C535046627 @default.
- W2017674012 hasConceptScore W2017674012C71924100 @default.
- W2017674012 hasConceptScore W2017674012C90673727 @default.
- W2017674012 hasConceptScore W2017674012C98274493 @default.
- W2017674012 hasIssue "2" @default.
- W2017674012 hasLocation W20176740121 @default.
- W2017674012 hasLocation W20176740122 @default.
- W2017674012 hasLocation W20176740123 @default.
- W2017674012 hasLocation W20176740124 @default.
- W2017674012 hasLocation W20176740125 @default.